The Benefits of Early Intervention In AD: More Than Skin Deep
Faculty
Eric
Simpson
MD, MSCR
Oregon Health and
Science University
Portland, Oregon, USA
Lawrence F.
Eichenfield
MD
University of
California and Rady
Children's Hospital
San Diego, California, USA
Katrina
Abuabara
MD, MA, MSCE
University of
California San Francisco
San Francisco,
California, USA
Learning objectives
- Present new data on the systemic burden of underlying type 2 inflammation in AD within and beyond the skin across age groups
- Discuss the cumulative life impact of uncontrolled AD and the importance of early intervention and disease control across age groups
- Relate perspectives on management of moderate-to-severe AD and the potential for disease modification
Agenda
Welcome, Introduction & Objectives
New Data on Systemic (Multi-Organ) Burden of AD in Children and the Need for Early Intervention
Panel Discussion
Importance of Achieving Disease Control in Adults with Moderate-to-Severe AD
Panel Discussion
Practical Considerations in Older Patients with AD
Panel Discussion
Perspectives on the Management of Patients with Moderate-to-Severe AD Across Age Groups
Summary and Conclusions
Panel Discussion and Live Q&A
Speakers will receive compensation for their participation in this event. This is a disease state awareness symposium. Speakers will not discuss specific treatments.
Faculty
Lawrence Eichenfield
MD
San Diego, USA
Sarina Elmariah
MD, PhD
San Francisco, USA
Brian Kim
MD
New York, USA
Eric Simpson
MD
Portland, USA
Katrina Abuabara
MD, MA, MSCE
San Francisco, USA
Martin Metz
MD
Berlin, Germany